Welcome to our dedicated page for Turning Pt Brands SEC filings (Ticker: TPB), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The Turning Point Brands, Inc. (NYSE: TPB) SEC filings page provides direct access to the company’s official regulatory disclosures as filed with the U.S. Securities and Exchange Commission. As a Delaware-incorporated manufacturer, marketer and distributor of Other Tobacco Products and modern oral nicotine products, Turning Point Brands uses these filings to report its financial condition, segment performance and material corporate events.
Core periodic reports such as the Form 10-K annual report and Form 10-Q quarterly reports contain detailed information on Zig-Zag and Stoker’s segment results, Modern Oral net sales, gross profit, liquidity, debt structure and risk factors related to tobacco and nicotine regulation. Investors can review how the company presents non-GAAP measures like Adjusted EBITDA and Adjusted Net Income alongside GAAP results, with reconciliations included in the filings or attached exhibits.
Current reports on Form 8-K document significant events, including quarterly earnings releases, changes to at-the-market equity offering programs, and other corporate actions. For example, TPB has filed 8-Ks describing its second and third quarter results and amendments to its ATM prospectus supplement, as well as legal opinions related to additional common stock that may be sold under its shelf registration statement.
Users can also monitor Form 4 insider transaction reports, proxy statements on Schedule 14A and other specialized forms to understand executive and director share activity, governance matters and compensation policies. Real-time updates from EDGAR ensure that new filings appear promptly, while AI-powered summaries help explain complex documents, highlight key figures and clarify segment trends so readers can navigate lengthy reports more efficiently.
Whether you are researching TPB’s Modern Oral growth, its capital structure, or the regulatory environment for its tobacco and nicotine products, this filings page serves as a centralized resource for the company’s official SEC disclosures and AI-assisted analysis.
TPB has a shareholder planning to sell 2,000 shares of its common stock on the NYSE through Fidelity Brokerage Services LLC. The notice lists an aggregate market value of 215460.00 for this planned sale.
The 2,000 shares were originally purchased on 05/21/2019 in an open-market transaction for cash or check, and 19070757 shares of this class were outstanding at the time referenced. By signing the notice, the seller represents that they are not aware of any material adverse information about the issuer’s current or prospective operations that has not been publicly disclosed.
Turning Point Brands, Inc. (TPB) President and CEO Graham Purdy reported a financing transaction tied to his company stock. On December 8, 2025, he entered into a forward-style financing with an unaffiliated dealer to receive approximately $12.3 million, secured by a pledge of up to 140,140 shares of Turning Point Brands common stock. Beginning on the maturity date of December 10, 2026, he must either repay the lender in cash or, at his election, deliver up to 140,140 shares at a price per share ranging from $91.50 to $104.45, depending on the market price at that time. Until then, he retains beneficial ownership of the pledged shares, including dividend and voting rights.
A holder of TPB common stock has filed a notice of proposed sale under Rule 144. The filing covers the potential sale of 140,140 shares of common stock through J.P. Morgan Securities LLC on the NYSE, with an indicated aggregate market value of $14,131,717 and with 19,070,757 shares outstanding for the issuer. The shares to be sold were originally acquired from the issuer as compensation in multiple grants between 2016 and 2025.
Turning Point Brands, Inc. (TPB) director reported modest open-market sales of company stock. On 11/19/2025, the reporting person sold 1,000 shares of common stock at a price of $101 per share, and on 11/20/2025 sold another 1,000 shares at a price of $102.54 per share, both coded as open-market sales. After these transactions, the reporting person beneficially owned 4,175 shares of common stock and restricted stock units in total, as described in the footnotes.
Turning Point Brands (TPB) insider trading disclosure: Senior Vice President and General Counsel Brittani Cushman reported multiple stock option exercises and same-day sales on 11/19/2025.
She exercised several blocks of Turning Point Brands common stock options, including 3,000, 4,000, 3,250 and 2,500 shares at exercise prices of $14.85, $21.21, $15.41 and $13.00, respectively, under the company’s 2015 Equity Incentive Plan. The exercised shares were then sold in matching amounts at a sale price of $101.66 per share.
After these transactions, Cushman directly beneficially owns 34,687 shares of common stock. The filing notes that certain totals in the table include 9,434 restricted stock units and 32,753 shares of common stock, and also that 406.806 shares are held indirectly by her spouse, for which she disclaims beneficial ownership.
Turning Point Brands, Inc. (TPB) reported an insider transaction by director Gregory Baxter on a Form 4. On 11/21/2025, Baxter sold 1,500 shares of TPB common stock in an open-market transaction coded as an "S" sale. The weighted average sale price was $98.23 per share, with individual trades executed at prices ranging from $97.64 to $98.95.
After this sale, Baxter beneficially owned a total of 38,919 TPB shares, consisting of 37,681 shares of common stock and 1,058 restricted stock units. The filing indicates the securities are held directly by the reporting person and that the report was filed by one reporting person rather than a group.
Turning Point Brands (TPB) insider Stephen Usher filed a Form 144 notice to sell common stock. The filing reports a planned sale of 1,000 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an aggregate market value of $102,540.00 and 19,070,757 shares outstanding at the time of the notice. These 1,000 shares were acquired on 05/08/2024 as restricted stock vesting under a registered plan from the issuer in exchange for services rendered. The form also notes that 1,000 common shares were sold on 11/19/2025 for gross proceeds of $101,000.00 during the prior three months. By signing, the seller represents they are not aware of undisclosed material adverse information about the company.
Turning Point Brands, Inc. (TPB) filed a notice of proposed sale of restricted stock under Rule 144. The filing covers the planned sale of 1,000 shares of common stock through Morgan Stanley Smith Barney LLC on the NYSE, with an indicated aggregate market value of $101,000.00. The securities were acquired as restricted stock vesting under a registered plan from the issuer on 05/08/2024, in connection with services rendered. The notice states that the seller does not know of any undisclosed material adverse information about the issuer’s current or prospective operations.
Turning Point Brands (TPB) reported insider activity by a director, who sold common stock over three consecutive days. On 11/11/2025, the director sold 15,000 shares at a weighted average price of $99.89. On 11/12/2025, 21,069 shares were sold at a weighted average price of $100.02. On 11/13/2025, 10,401 shares were sold at a weighted average price of $99.03. The reported prices reflect multiple trades within disclosed ranges.
Following the transactions, beneficial ownership reported in Column 5 progressed to 315,186, then 290,765, and finally 280,368 shares, all held directly. The filing also lists outstanding stock options with various exercise prices and expirations under the company’s equity plan.
TPB filed a Rule 144 notice for a proposed sale of up to 50,000 shares of common stock through UBS Financial Services on the NYSE, with an aggregate market value of $4,950,000. The approximate sale date is 11/11/2025.
The shares were acquired via restricted stock releases on 02/14/2023 and 05/25/2023, and stock option exercises on 06/15/2017, 09/17/2018, and 09/18/2018, totaling 50,000 shares. Shares outstanding were 19,070,757; this is a baseline figure, not the amount being offered.